About this trial
The goal of this observational study is to analyze the acute effects of meteorological factors and air pollution on cardiovascular system. The main question it aims to answer is:
1. How do meteorological factors and air pollution affect cardiovascular system? 2. What is the interaction between meteorological factors and air pollution on cardiovascular system?
Participants will:
1. Provide their health data obtained in physical examination, including but not limited to blood pressure, blood routine, urine routine and B-ultrasound. 2. agree that the research team will use their personal identification number, gender, age, education level and other information for statistical analysis of the data.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Relevant records in the physical examination database shall be ≥3times
Serious heart and lung diseases
Malignant tumors
Serious mental illness in the past
Trial population
1. Target population: adults who have been recorded at least three times in the physical examination database will be included in this study. This requirement aims to ensure that the participants\' health status can be fully evaluated historically, and then to study the changes of various health indicators over time. 2. Sample source and recruitment: Participants will be selected from the routine physical examination database of several hospital physical examination centers in Zhejiang, Henan, Anhui, Guizhou and other provinces.
Trial design
Cohort
Retrospective
Treatments tested in this trial
NOT
Other interventionThis retrospective cohort study involves no new interventions. It analyzes existing health data collected from subjects exposed to varying atmospheric conditions to assess impacts on health outcomes.
Treatment groups
Trial outcomes
Primary outcomes
Troponin
Troponin data were obtained by blood biochemical detection data recorded in the diagnosis and treatment system, with unit of µg/L.
Blood pressure
Blood pressure data were obtained from the diagnosis and treatment record system and analyzed by standard sphygmomanometer, with unit of mmHg.
Secondary outcomes
Left ventricular ejection fraction(LVEF)
Left ventricular ejection fraction(LVEF)data were obtained by Cardiac color ultrasound data recorded in the diagnosis and treatment system, with unit of %
White cell count
White cell count data were obtained by blood routine blood data recorded in the diagnosis and treatment system, with unit of 10\^9/L
Controlled Attenuation Parameter(CAP)
Controlled Attenuation Parameter(CAP)data were obtained by Diagnosis of hepatic fibrosis data recorded in the diagnosis and treatment system, with unit of dB/m.
ST segment of electrocardiogram
ST segment were obtained by Electrocardiogram (ECG) recorded in the diagnosis and treatment system with unit of mV.
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.